SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Jun 21, 2023

2. SEC Identification Number

148022

3. BIR Tax Identification No.

000-288-655-000

4. Exact name of issuer as specified in its charter

Euro-Med Laboratories Phil., Inc.

5. Province, country or other jurisdiction of incorporation

Metro Manila

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

PPL Building, United Nations Avenue corner San Marcelino St., Manila Postal Code 1007

8. Issuer's telephone number, including area code

00-63-2-85240091 to 98

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
common shares	4,112,140,540

11. Indicate the item numbers reported herein

Item 9 : Other Events

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Euro-Med Laboratories Phil., Inc.EURO

PSE Disclosure Form 4-24 - Results of Annual or Special Stockholders' Meeting References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Results of the Annual Shareholders’ Meeting
Background/Description of the Disclosure
Euro-Med Laboratories Phil., Inc. (the “Corporation”) held its Annual Shareholders’ Meeting today, 21 June 2023 conducted virtually via http://meeting.euromedlab.net at 10:00 o’clock in the morning. All of the members of the Board of Directors were present at the meeting.

List of elected directors for the ensuing year with their corresponding shareholdings in the Issuer

Name of Person	Shareholdings in the Listed Company		Nature of Indirect Ownership
	Direct	Indirect
Dr. William G. Padolina	20,564	0	-
Mr. Edwin D. Feist	11,607	0	-
Mrs. Georgiana S. Evidente	1,285,052	0	-
Evangeline V. Baviera, M.D.	41,645	0	-
Esperanza I. Cabral, M.D.	1,000	0	-
Mr. Anthony Joseph Y. Gaw	586,617	0	-
Dr. Johnny C. Yap	36,980,720	568,393	owns a share from the majority stockholder
Mr. Benjamin C. Yap	1,000	1,767,402	owns a share from the majority stockholder
Mr. Basilio C. Yap	20,564	1,755,190	owns a share from the majority stockholder
Dr. Enrique Y. Yap, Jr.	41,125	738,515	owns a share from the majority stockholder

External auditor	Aquino, Mata, Calica and Associates

List of other material resolutions, transactions and corporate actions approved by the stockholders
The stockholders likewise approved the following : 1. Minutes of the previous Annual Shareholders’ Meeting held on June 15, 2022; 2. Management Report for Fiscal Year 2022; 3. Ratifications, Proceedings and Resolutions of the Board of Directors and Officers of the Corporation from June 15, 2022 up to the date of this year’s Annual Shareholders’ Meeting; and 4. Re-Nomination of Dr. William G. Padolina and Mr. Edwin D. Feist as Independent Directors
Other Relevant Information
None